Cellid

Developer of personalized vaccines to treat cancer and infectious diseases

placeSeoul, Seoul, South Korea calendar_todayFounded 2014 groups68 employees language cellid.co.kr

Innovation

9 patent families (3 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace steady. Cited 205 times.

YearFilings
20141
20161
20171
20191
20211
20223
20235
20243
20253
20261

Investor mix

11 investors on record; lead investors include DSC Investment, DAOL Investment; 2 have since exited.

Investor typeCountShare
Venture capital545%
Private equity218%
Other / undisclosed436%
Coming soon